Literature DB >> 4372252

Hereditary hemolytic anemia with human erythrocyte pyrimidine 5'-nucleotidase deficiency.

W N Valentine, K Fink, D E Paglia, S R Harris, W S Adams.   

Abstract

A severe deficiency of a red cell pyrimidine 5'-nucleotidase was found to be associated with hereditary hemolytic anemia in four members of three kindreds. The syndrome was characterized by marked increases above normal in red cell basophilic stippling, total nucleotides, and GSH and by a fairly severe deficiency of ribosephosphate pyrophosphokinase (EC 2.7.6.1.). Patient erythrocytes uniquely contained large amounts of pyrimidine 5'-ribonucleotides. In earlier studies, these were erroneously considered to be adenosine phosphates, since all previous investigations of the nucleotides of human red cells and reticulocytes have shown 97% or more to contain adenine. Total nucleotides in patient cells were present in amounts 3-6 times greater than normal, and approximately 80% contained pyrimidine. The ultraviolet spectral curves of deproteinized red cell extracts exhibited a shift in maximum absorbance from the usual 256-257 nm to approximately 266-270 nm, and absorbance at 250, 270, 280, and 290 nm, expressed as a ratio of that at 260 nm, differed greatly from normal. The spectral characteristics of extracts provide the basis of a readily performed screening procedure, which does not require enzyme assay. The nucleotidase activity in deficient red cells assayed less than 14%, and usually less than 10%, of normal and much less in terms of reticulocyte-rich blood, where it was consistently found to be increased. The enzyme has a pH optimum of 7.5-8.0, is inhibited by EDTA, and does not utilize purine 5'-ribonucleotides or beta-glycerophosphate as substrates. While comparatively few family members have been available thus far for study, initial data are compatible with an autosomal, recessive mode of transmission of the deficiency. The pyrimidine 5'-ribonucleotides are presumably derived from RNA degradation and, not being diffusible, accumulate when the enzyme catalyzing their dephosphorylation is deficient. It is postulated that the prominent basophilic stippling results from retarded ribosomal RNA degradation secondary to accumulation of degradation products, namely pyrimidine 5'-ribonucleotides. Ribosephosphate pyrophosphokinase deficiency is considered to be an epiphenomenon. The mechanism responsible for increased red cell GSH is unknown.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4372252      PMCID: PMC301626          DOI: 10.1172/JCI107826

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Studies on human erythrocyte nucleotide metabolism. I. Monisotopic methodologies.

Authors:  W N Valentine; K K Kürschner
Journal:  Blood       Date:  1972-05       Impact factor: 22.113

2.  Studies on erythrocyte glycolysis. I. Determination of the glycolytic intermediates in human erythrocytes.

Authors:  S Minakami; C Suzuki; T Saito; H Yoshikawa
Journal:  J Biochem       Date:  1965-12       Impact factor: 3.387

3.  Studies on human erythrocyte nucleotide metabolism. II. Nonspherocytic hemolytic anemia, high red cell ATP, and ribosephosphate pyrophosphokinase (RPK, E.C.2.7.6.1) deficiency.

Authors:  W N Valentine; H M Anderson; D E Paglia; E R Jaffé; P N Konrad; S R Harris
Journal:  Blood       Date:  1972-05       Impact factor: 22.113

4.  Erythrocyte glyoxalase II deficiency with coincidental hereditary elliptocytosis.

Authors:  W N Valentine; D E Paglia; R C Neerhout; P N Konrad
Journal:  Blood       Date:  1970-12       Impact factor: 22.113

5.  Kinetic comparison of genetically different acid phosphatases of human erythrocytes.

Authors:  E M Scott
Journal:  J Biol Chem       Date:  1966-07-10       Impact factor: 5.157

6.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

Authors:  D E Paglia; W N Valentine
Journal:  J Lab Clin Med       Date:  1967-07

7.  Hereditary hemolytic anemia with hexokinase deficiency. Role of hexokinase in erythrocyte aging.

Authors:  W N Valentine; F A Oski; D E Paglia; M A Baughan; A S Schneider; J L Naiman
Journal:  N Engl J Med       Date:  1967-01-05       Impact factor: 91.245

8.  Paper chromatographic data for purines, pyrimidines and derivatives in a variety of solvents.

Authors:  K Fink; W S Adams
Journal:  J Chromatogr       Date:  1966-04

9.  The adenylate kinase of human plasma, erythrocytes and platelets in relation to the degradation of adenosine diphosphate in plasma.

Authors:  R J Haslam; D C Mills
Journal:  Biochem J       Date:  1967-06       Impact factor: 3.857

10.  Hereditary hemolytic anemia associated with glucosephosphate isomerase (GPI) deficiency--a new enzyme defect of human erythrocytes.

Authors:  M A Baughan; W N Valentine; D E Paglia; P O Ways; E R Simons; Q B DeMarsh
Journal:  Blood       Date:  1968-08       Impact factor: 22.113

View more
  43 in total

1.  Effects of low-level lead exposure on pyrimidine 5'-nucleotidase and other erythrocyte enzymes. Possible role of pyrimidine 5'-nucleotidase in the pathogenesis of lead-induced anemia.

Authors:  D E Paglia; W N Valentine; J G Dahlgren
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

Review 2.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 3.  Structures of proteins of biomedical interest from the Center for Eukaryotic Structural Genomics.

Authors:  George N Phillips; Brian G Fox; John L Markley; Brian F Volkman; Euiyoung Bae; Eduard Bitto; Craig A Bingman; Ronnie O Frederick; Jason G McCoy; Betsy L Lytle; Brad S Pierce; Jikui Song; Simon N Twigger
Journal:  J Struct Funct Genomics       Date:  2007-09-06

4.  Three cases of hereditary hemolytic anemia with pyrimidine 5'-nucleotidase deficiency in a Japanese family.

Authors:  S Miwa; K Nakashima; H Fujii; M Matsumoto; K Nomura
Journal:  Hum Genet       Date:  1977-07-26       Impact factor: 4.132

5.  Electrophoretic and kinetic studies of human erythrocytes deficient in pyrimidine 5'-nucleotidase.

Authors:  R Rosa; H Rochant; B Dreyfus; C Valentin; J Rosa
Journal:  Hum Genet       Date:  1977-09-22       Impact factor: 4.132

6.  Deficiency of pyrimidine 5'-nucleotidase in human leukocytes.

Authors:  D de Korte; C C van Doorn; J M Sijstermans; A H van Gennip; D Roos
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

7.  Identification of Drosophila and human 7-methyl GMP-specific nucleotidases.

Authors:  Juliane Buschmann; Bodo Moritz; Mandy Jeske; Hauke Lilie; Angelika Schierhorn; Elmar Wahle
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

8.  Lead poisoning: association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine 5'-nucleotidase deficiency, and intraerythrocytic accumulation of pyrimidines.

Authors:  W N Valentine; D E Paglia; K Fink; G Madokoro
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

9.  Erythrocyte nucleotides in lead workers.

Authors:  M Ichiba; K Tomokuni; K Mori
Journal:  Int Arch Occup Environ Health       Date:  1992       Impact factor: 3.015

10.  Lead poisoning: clinical, biochemical, and haematological aspects of a recent outbreak.

Authors:  A Pagliuca; G J Mufti; D Baldwin; A N Lestas; R M Wallis; A J Bellingham
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.